Systemic antibiotic agents.

N S Sadick

doi:10.1016/s0733-8635(05)70226-6

Home/Archive/PubMed

PubMed · 11155575

Systemic antibiotic agents.

N S Sadick

View original source ↗Export metadata ↓

Abstract

Understanding the breadth of systemic antimicrobial agents available for use by the dermatologist and their associated side-effect profiles and drug interactions allows the clinician to offer patients optimal care in the management of cutaneous infectious disease.

Explore related subjects

Administration, Oral Anti-Bacterial Agents Drug Interactions Drug Therapy, Combination Humans Injections, Intravenous Skin Diseases, Infectious Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

N S Sadick. 2001. Systemic antibiotic agents.. https://doi.org/10.1016/s0733-8635(05)70226-6

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Novel potent antagonists of human neuropeptide Y-Y5 receptor. Part 4: tetrahydrodiazabenzazulene derivatives.

Novel tetrahydrodiazabenzazulene derivatives, designed from the lead compound 1 discovered by screening of our in-house chemical library, were prepared and found to be potent neuropeptide Y-Y5 (NPY-Y5) receptor antagonists. The structure-activity relationships are described. Compounds 7 (FR240662) and 16 (FR252384) were especially attractive owing to their high affinities for the NPY-Y5 receptors, oral absorption and permeability to brain.

Administration, Oral↗

PubMed2002

Noncovalent tripeptidic thrombin inhibitors incorporating amidrazone, amine and amidine functions at P1.

A series of noncovalent tripeptidic thrombin inhibitors incorporating amidrazone, amine and amidine functions at P1 was investigated. While the amidrazone and the amine series displayed limited oral absorption, the amidine series demonstrated generally good oral absorption and strong antithrombotic activity; the single-digit picomolar K(i) achieved from this series is among the best yet reported. The present work highlights the benzamidine compound 11f (LB30812) that exhibits excellent overall profiles of potency, oral absorption and antithrombotic efficacy.

Administration, Oral↗

PubMed2002

Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 3: synthesis and SAR of potent and specific 2,8-diazaspiro[4.5]decanes.

The synthesis and biological activity of analogues containing spiro piperidinylpyridine and pyrrolidinylpyridine templates are described. The potent activity of these compounds as platelet aggregation inhibitors demonstrates the utility of the spiro structures as central template for nonpeptide RGD mimics.

Administration, Oral↗